Among these biomarkers are those associated with the theory of inflammation and neurotrophic factors involved in neuroplasticity, such as VEGF, which can help predict susceptibility to the development of depression and response to drug treatment [44]. This evidence concerns the gene VEGFA and depressive symptom measurement.